Ca-A Cancer Journal for Clinicians, volume 73, issue 1, pages 17-48
Cancer statistics, 2023
Rebecca L. Siegel
1
,
Kimberly D Miller
1
,
Nikita Sandeep Wagle
1
,
Ahmedin Jemal
1
Publication type: Journal Article
Publication date: 2023-01-12
Journal:
Ca-A Cancer Journal for Clinicians
scimago Q1
SJR: 106.094
CiteScore: 873.2
Impact factor: 503.1
ISSN: 00079235, 15424863
PubMed ID:
36633525
Oncology
Hematology
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using incidence data collected by central cancer registries and mortality data collected by the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases; otherwise, however, incidence trends were more favorable in men compared to women. For example, lung cancer in women decreased at one half the pace of men (1.1% vs. 2.6% annually) from 2015 through 2019, and breast and uterine corpus cancers continued to increase, as did liver cancer and melanoma, both of which stabilized in men aged 50 years and older and declined in younger men. However, a 65% drop in cervical cancer incidence during 2012 through 2019 among women in their early 20s, the first cohort to receive the human papillomavirus vaccine, foreshadows steep reductions in the burden of human papillomavirus‐associated cancers, the majority of which occur in women. Despite the pandemic, and in contrast with other leading causes of death, the cancer death rate continued to decline from 2019 to 2020 (by 1.5%), contributing to a 33% overall reduction since 1991 and an estimated 3.8 million deaths averted. This progress increasingly reflects advances in treatment, which are particularly evident in the rapid declines in mortality (approximately 2% annually during 2016 through 2020) for leukemia, melanoma, and kidney cancer, despite stable/increasing incidence, and accelerated declines for lung cancer. In summary, although cancer mortality rates continue to decline, future progress may be attenuated by rising incidence for breast, prostate, and uterine corpus cancers, which also happen to have the largest racial disparities in mortality.
Found
Found
Top-30
Journals
50
100
150
200
250
300
350
400
|
|
Cancers
395 publications, 3.63%
|
|
Frontiers in Oncology
288 publications, 2.65%
|
|
Scientific Reports
206 publications, 1.89%
|
|
International Journal of Molecular Sciences
197 publications, 1.81%
|
|
Frontiers in Immunology
144 publications, 1.32%
|
|
BMC Cancer
129 publications, 1.19%
|
|
Heliyon
123 publications, 1.13%
|
|
Frontiers in Pharmacology
87 publications, 0.8%
|
|
Discover Oncology
80 publications, 0.74%
|
|
bioRxiv : the preprint server for biology
79 publications, 0.73%
|
|
Cancer Medicine
76 publications, 0.7%
|
|
Gynecologic Oncology
65 publications, 0.6%
|
|
Cancer Letters
64 publications, 0.59%
|
|
Cureus
60 publications, 0.55%
|
|
Journal of Cancer Research and Clinical Oncology
59 publications, 0.54%
|
|
International Journal of Biological Macromolecules
57 publications, 0.52%
|
|
Biomedicines
55 publications, 0.51%
|
|
Annals of Surgical Oncology
52 publications, 0.48%
|
|
Journal of Translational Medicine
51 publications, 0.47%
|
|
Advanced Science
49 publications, 0.45%
|
|
Biomedicine and Pharmacotherapy
48 publications, 0.44%
|
|
Cancer Cell International
48 publications, 0.44%
|
|
Cell Death and Disease
48 publications, 0.44%
|
|
Pharmaceutics
47 publications, 0.43%
|
|
Diagnostics
46 publications, 0.42%
|
|
Journal of Clinical Medicine
46 publications, 0.42%
|
|
iScience
44 publications, 0.4%
|
|
Molecules
41 publications, 0.38%
|
|
PLoS ONE
41 publications, 0.38%
|
|
50
100
150
200
250
300
350
400
|
Publishers
500
1000
1500
2000
2500
3000
|
|
Elsevier
2579 publications, 23.72%
|
|
Springer Nature
2393 publications, 22.01%
|
|
MDPI
1251 publications, 11.51%
|
|
Wiley
917 publications, 8.43%
|
|
Frontiers Media S.A.
726 publications, 6.68%
|
|
Taylor & Francis
349 publications, 3.21%
|
|
American Chemical Society (ACS)
222 publications, 2.04%
|
|
Ovid Technologies (Wolters Kluwer Health)
220 publications, 2.02%
|
|
Cold Spring Harbor Laboratory
177 publications, 1.63%
|
|
Institute of Electrical and Electronics Engineers (IEEE)
164 publications, 1.51%
|
|
Oxford University Press
145 publications, 1.33%
|
|
SAGE
132 publications, 1.21%
|
|
Research Square Platform LLC
109 publications, 1%
|
|
American Association for Cancer Research (AACR)
96 publications, 0.88%
|
|
Royal Society of Chemistry (RSC)
93 publications, 0.86%
|
|
American Society of Clinical Oncology (ASCO)
83 publications, 0.76%
|
|
BMJ
79 publications, 0.73%
|
|
Spandidos Publications
76 publications, 0.7%
|
|
Bentham Science Publishers Ltd.
53 publications, 0.49%
|
|
Baishideng Publishing Group
47 publications, 0.43%
|
|
Impact Journals
45 publications, 0.41%
|
|
Public Library of Science (PLoS)
44 publications, 0.4%
|
|
Mary Ann Liebert
29 publications, 0.27%
|
|
American Medical Association (AMA)
24 publications, 0.22%
|
|
PeerJ
22 publications, 0.2%
|
|
Hans Publishers
22 publications, 0.2%
|
|
IOP Publishing
22 publications, 0.2%
|
|
S. Karger AG
22 publications, 0.2%
|
|
500
1000
1500
2000
2500
3000
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Siegel R. L. et al. Cancer statistics, 2023 // Ca-A Cancer Journal for Clinicians. 2023. Vol. 73. No. 1. pp. 17-48.
GOST all authors (up to 50)
Copy
Siegel R. L., Miller K. D., Wagle N. S., Jemal A. Cancer statistics, 2023 // Ca-A Cancer Journal for Clinicians. 2023. Vol. 73. No. 1. pp. 17-48.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3322/caac.21763
UR - https://doi.org/10.3322/caac.21763
TI - Cancer statistics, 2023
T2 - Ca-A Cancer Journal for Clinicians
AU - Siegel, Rebecca L.
AU - Miller, Kimberly D
AU - Wagle, Nikita Sandeep
AU - Jemal, Ahmedin
PY - 2023
DA - 2023/01/12
PB - Wiley
SP - 17-48
IS - 1
VL - 73
PMID - 36633525
SN - 0007-9235
SN - 1542-4863
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2023_Siegel,
author = {Rebecca L. Siegel and Kimberly D Miller and Nikita Sandeep Wagle and Ahmedin Jemal},
title = {Cancer statistics, 2023},
journal = {Ca-A Cancer Journal for Clinicians},
year = {2023},
volume = {73},
publisher = {Wiley},
month = {jan},
url = {https://doi.org/10.3322/caac.21763},
number = {1},
pages = {17--48},
doi = {10.3322/caac.21763}
}
Cite this
MLA
Copy
Siegel, Rebecca L., et al. “Cancer statistics, 2023.” Ca-A Cancer Journal for Clinicians, vol. 73, no. 1, Jan. 2023, pp. 17-48. https://doi.org/10.3322/caac.21763.
Found error?
Found error?
Publisher
scimago Q1
SJR
106.094
CiteScore
873.2
Impact factor
503.1
ISSN
00079235
(Print)
15424863
(Electronic)